BSE filing, BSE: 544694. Summary written from the filing by ALFA Finder's alert engine.
Accretion Nutraveda Ltd: key numbers
- Share price
- ₹290.00
- Market cap
- ₹210.0 Cr
- Revenue (annual)
- ₹33.60 Cr
- Net profit (annual)
- ₹5.07 Cr
- P/E (TTM)
- 41.4×Sector 46.1×
- Promoter holding
- 73.48%+0.00% QoQ
- FII holding
- 1.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Accretion Nutraveda Ltd
All →Accretion Nutraveda Board Meeting Date
Accretion Nutraveda will hold a board meeting on 31 October 2026 to consider unaudited financial results for the half year ended September 2026. The intimation is a prior notice under Regulation 29.
Accretion Nutraveda Annual General Meeting
Accretion Nutraveda Limited announced results of its postal ballot. Shareholders approved special resolutions regarding MOA alteration, borrowing limits, and various loan and guarantee authorizations.
Accretion Nutraveda Other Announcement
Accretion Nutraveda Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory disclosure under SEBI LODR.
Accretion Nutraveda Annual General Meeting
Accretion Nutraveda Limited issued a Notice of Postal Ballot to seek shareholder approval for the alteration of its Memorandum of Association. Voting concludes on October 9, 2026.
Accretion Nutraveda Annual General Meeting
Accretion Nutraveda Limited held its 5th Annual General Meeting on 27th August, 2026, where shareholders transacted routine business, including the adoption of financial statements.
Accretion Nutraveda Other Announcement
Accretion Nutraveda Limited informed shareholders of the weblink to access the FY 2025-26 Annual Report and notice for the 5th Annual General Meeting.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.